Debt-to-equity in % of Nascent Biotech Inc. from Q3 2015 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Nascent Biotech Inc. quarterly Debt-to-equity history and change rate from Q3 2015 to Q2 2024.
  • Nascent Biotech Inc. Debt-to-equity for the quarter ending 30 Jun 2024 was -430 %, a 200% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Nascent Biotech Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q2 2024 -430 -287 -200% 30 Jun 2024
Q1 2024 -275 -133 -93.9% 31 Mar 2024
Q4 2023 -186 -42.1 -29.2% 31 Dec 2023
Q3 2023 -152 +7.44 +4.65% 30 Sep 2023
Q2 2023 -143 -11.3 -8.59% 30 Jun 2023
Q1 2023 -142 -0.43 -0.3% 31 Mar 2023
Q4 2022 -144 +23.2 +13.9% 31 Dec 2022
Q3 2022 -160 -26.2 -19.6% 30 Sep 2022
Q2 2022 -132 +3.99 +2.94% 30 Jun 2022
Q1 2022 -141 -17.7 -14.3% 31 Mar 2022
Q4 2021 -167 -64.5 -62.8% 31 Dec 2021
Q3 2021 -134 -31.9 -31.4% 30 Sep 2021
Q2 2021 -136 -35.6 -35.6% 30 Jun 2021
Q1 2021 -124 -23.3 -23.2% 31 Mar 2021
Q4 2020 -103 +2.26 +2.15% 31 Dec 2020
Q3 2020 -102 +8.52 +7.73% 30 Sep 2020
Q2 2020 -100 +17.5 +14.8% 30 Jun 2020
Q1 2020 -100 +22.9 +18.6% 31 Mar 2020
Q4 2019 -105 +24.2 +18.7% 31 Dec 2019
Q3 2019 -110 +655 +85.6% 30 Sep 2019
Q2 2019 -118 -180 -290% 30 Jun 2019
Q1 2019 -123 -152 -525% 31 Mar 2019
Q4 2018 -129 -150 -728% 31 Dec 2018
Q3 2018 -765 -786 -3669% 30 Sep 2018
Q2 2018 62 +40.4 +187% 30 Jun 2018
Q1 2018 29 -87.8 -75.1% 31 Mar 2018
Q4 2017 20.6 +1.13K 31 Dec 2017
Q3 2017 21.4 +347 30 Sep 2017
Q2 2017 21.6 +224 30 Jun 2017
Q1 2017 117 +289 31 Mar 2017
Q4 2016 -1.11K -954 -605% 31 Dec 2016
Q3 2016 -326 -182 -127% 30 Sep 2016
Q2 2016 -203 30 Jun 2016
Q1 2016 -173 31 Mar 2016
Q4 2015 -158 31 Dec 2015
Q3 2015 -144 30 Sep 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.